About TetraAs
about_tetraas_980

Description of TetraAs anticancer drug

CHEMICAL
STRUCTURE

As4O6 (Arsenic hexoxide, molecular weight 395.6)

MECHANISM

  • Anti-angiogenesis
  • Induction of apoptosis
  • Anti-NF-KB activity which is generally increased in advanced cancer

ACTION

  • Effective in treating various solid cancers including cervical cancer, lung cancer, brain cancer, renal cancer, bladder cancer, and maxillary sinus cancer
  • Effective in treating blood cancers such as multiple myeloma
  • Very effective in reducing cancer pain

ADVANTAGE

  • Oral administration
  • Almost no side effects or drug tolerance
  • Increase in efficacy when used in combination therapy with radiation and other anti-cancer drugs
  • Sufficient safety margin
  • Possible to develop injectable version
  • Very effective in treating cancer pain

Advantage of TetraAs (As4O6)

21_about_tetraas_001
21_about_tetraas_002
21_about_tetraas_003
21_about_tetraas_004_0728
Search